Atorvastatin Calcium
NDC 81033-514, Atorvastatin Calcium, tablet, film coated, from Kesin Pharma Corporation.
- Product NDC
- 81033-514
- Status
- Listed
- Labeler
- Kesin Pharma Corporation
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209288
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81033-514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATORVASTATIN CALCIUM TRIHYDRATE80 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81033-514-01 | 81033051401 | 10 BLISTER PACK in 1 CARTON (81033-514-01) / 100 TABLET, FILM COATED in 1 BLISTER PACK (81033-514-40) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/56826bb5-ae70-af65-e063-6294a90abf74
Use it
Look up 81033-514 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81033-514 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81033-514. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.